Literature DB >> 31958380

Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction.

Hanieh Mohammadi1, Joel Ohm2,3, Andrea Discacciati4, Johan Sundstrom5, Kristina Hambraeus6, Tomas Jernberg7, Per Svensson1,8.   

Abstract

BACKGROUND: The association between abdominal obesity and recurrent atherosclerotic cardiovascular disease after myocardial infarction remains unknown.
OBJECTIVE: The purpose of this study was to investigate the prevalence of abdominal obesity and its association with recurrent atherosclerotic cardiovascular disease in patients after a first myocardial infarction. DESIGN AND METHODS: In this register-based observational cohort, 22,882 patients were identified from the national Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) registry at a clinical revisit 4-10 weeks after their first myocardial infarction 2005-2014. Patients were followed for recurrent atherosclerotic cardiovascular disease defined as non-fatal myocardial infarction, coronary heart disease death, non-fatal or fatal ischaemic stroke. Univariate and multivariable-adjusted Cox regression models were used to calculate hazard ratios and 95% confidence intervals in quintiles of waist circumference as well as three categories of body mass index including normal weight, overweight and obesity.
RESULTS: The majority of patients had abdominal obesity. During a median follow-up time of 3.8 years, 1232 men (7.3%) and 469 women (7.9%) experienced a recurrent atherosclerotic cardiovascular disease event. In the univariate analysis, risk was elevated in the fifth quintile (hazard ratio 1.22, 95% confidence interval 1.07-1.39) compared with the first. In the multivariable-adjusted analysis, risk was elevated in the fourth and fifth quintiles (hazard ratio 1.21, confidence interval 1.03-1.43 and hazard ratio 1.25, confidence interval 1.04-1.50), respectively. Gender-stratified analyses showed similar associations in men, while U-shaped associations were observed in women and the body mass index analyses.
CONCLUSIONS: Abdominal obesity was common in post-myocardial infarction patients and larger waist circumference was independently associated with recurrent atherosclerotic cardiovascular disease, particularly in men. We recommend utilising waist circumference to identify patients at increased risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction.

Entities:  

Keywords:  Waist circumference; abdominal obesity; atherosclerotic cardiovascular disease; body mass index; myocardial infarction; secondary prevention

Year:  2020        PMID: 31958380     DOI: 10.1177/2047487319898019

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  4 in total

1.  Sex differences in the association between dinner-bedtime interval and abdominal obesity: a large-scale cross-sectional study.

Authors:  Yuanyuan Chai; Chenling Qu; Zhenxing Mao; Chongjian Wang; Songcheng Yu
Journal:  Eat Weight Disord       Date:  2022-09-27       Impact factor: 3.008

2.  Factors Associated With Myocardial Infarction Reoccurrence.

Authors:  Willie M Abel; Lauren N Scanlan; Carolyn E Horne; Patricia B Crane
Journal:  J Cardiovasc Nurs       Date:  2021-02-28       Impact factor: 2.468

3.  Association of Socioeconomic Status With Risk Factor Target Achievements and Use of Secondary Prevention After Myocardial Infarction.

Authors:  Joel Ohm; Per H Skoglund; Henrike Häbel; Johan Sundström; Kristina Hambraeus; Tomas Jernberg; Per Svensson
Journal:  JAMA Netw Open       Date:  2021-03-01

4.  Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study.

Authors:  Marcelino Bermúdez-López; Manuel Martí-Antonio; Eva Castro-Boqué; María Del Mar Bretones; Cristina Farràs; Gerard Torres; Reinald Pamplona; Albert Lecube; Dídac Mauricio; José Manuel Valdivielso; Elvira Fernández
Journal:  Front Cardiovasc Med       Date:  2022-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.